EFFICIENT CD28 SIGNALING LEADS TO INCREASES IN THE KINASE-ACTIVITIES OF THE TEC FAMILY TYROSINE KINASE EMT ITK/TSK AND THE SRC FAMILY TYROSINE KINASE LCK/
S. Gibson et al., EFFICIENT CD28 SIGNALING LEADS TO INCREASES IN THE KINASE-ACTIVITIES OF THE TEC FAMILY TYROSINE KINASE EMT ITK/TSK AND THE SRC FAMILY TYROSINE KINASE LCK/, Biochemical journal, 330, 1998, pp. 1123-1128
Optimal T cell activation requires crosslinking of the T cell receptor
(TCR) concurrently with an accessory receptor, most efficiently CD28.
Crosslinking of CD28 leads to increased interleukin 2 (IL2) productio
n, inhibition of anergy and prevention of programmed cell death. Cross
linking of CD28 leads to rapid increases in tyrosine phosphorylation o
f specific intracellular substrates including CD28 itself. Since CD28
does not encode an intrinsic tyrosine kinase domain, CD28 must activat
e an intracellular tyrosine kinase(s). Indeed, crosslinking of CD28 in
creases the activity of the intracellular tyrosine kinases EMT/ITK and
LCK, The phosphatidylinositol 3-kinase (PI3K) and GRB2 binding site i
n CD28 is dispensable for optimal IL2 production in Jurkat T cells, We
demonstrate herein that murine Y170 (equivalent to human Y173) in CD2
8 is also dispensable for activation of the SRC family tyrosine kinase
LCK and the TEC family tyrosine kinase EMT/ITK. In contrast, the dist
al three tyrosines in CD28 are required for optimal IL2 production as
well as for optimal activation of the LCK and EMT/ITK tyrosine kinases
. The distal three tyrosines of CD28, however, are not required for re
cruitment of PI3K to CD28. Furthermore, PI3K is recruited to CD28 in J
CaM1 cells which lack LCK and in which EMT/ITK is not activated by lig
ation of CD28. Thus optimal activation of LCK or EMT/ITK is not obliga
tory for recruitment of PI3K to CD28 and thus is also not required for
tyrosine phosphorylation of the YMNM motif in CD28. Taken together th
e data indicate that the distal three tyrosines in CD28 are integral t
o the activation of LCK and EMT/ITK and for subsequent IL2 production.